Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
Sideromycins have demonstrated bactericidal activity against -lactamase producing Enterobacterales, and other antibiotic-resistant strains of P
Same warning, different vantage points
The remaining work to be done is scale, not foundation.
US$ 22.50
US$ 22.87
US$ 22.75
US$ 21.29
US$ 22.61
US$ 27.42
US$ 22.99
